Eton Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Eton Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ETON.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate...
Can you invest in Eton Pharmaceuticals, Inc.?
Yes. Eton Pharmaceuticals, Inc. trades publicly on NASDAQ as ETON.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Eton Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.